Ledger.Open graph →
SEC Form D · filed December 30, 2019

TwinStrand Biosciences, Inc

Offering
$16.3M
Sold
$16.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jesse Salk · Bellevue, WAExec · Director · PromoterChad Waite · Somerville, MAExec · DirectorMichele Fernandes · Seattle, WAExecTerry Myerson · Seattle, WADirectorSteve Dow · Somerville, MADirectorJesse Salk · Bellevue, WAExec · Director · PromoterChad Waite · Seattle, WAExec · DirectorMichele Fernandes · Seattle, WAExecTerry Myerson · Seattle, WADirectorSteve Dow · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗